Home > Research > Publications & Outputs > IR microspectroscopy: potential applications in...
View graph of relations

IR microspectroscopy: potential applications in cervical cancer screening.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

IR microspectroscopy: potential applications in cervical cancer screening. / Walsh, Michael J.; German, Matthew J.; Singh, Maneesh et al.
In: Cancer Letters, Vol. 246, No. 1-2, 08.02.2007, p. 1-11.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Walsh, MJ, German, MJ, Singh, M, Pollock, HM, Hammiche, A, Kyrgiou, M, Stringfellow, HF, Paraskevaidis, E, Martin-Hirsch, PL & Martin, FL 2007, 'IR microspectroscopy: potential applications in cervical cancer screening.', Cancer Letters, vol. 246, no. 1-2, pp. 1-11. https://doi.org/10.1016/j.canlet.2006.03.019

APA

Walsh, M. J., German, M. J., Singh, M., Pollock, H. M., Hammiche, A., Kyrgiou, M., Stringfellow, H. F., Paraskevaidis, E., Martin-Hirsch, P. L., & Martin, F. L. (2007). IR microspectroscopy: potential applications in cervical cancer screening. Cancer Letters, 246(1-2), 1-11. https://doi.org/10.1016/j.canlet.2006.03.019

Vancouver

Walsh MJ, German MJ, Singh M, Pollock HM, Hammiche A, Kyrgiou M et al. IR microspectroscopy: potential applications in cervical cancer screening. Cancer Letters. 2007 Feb 8;246(1-2):1-11. doi: 10.1016/j.canlet.2006.03.019

Author

Walsh, Michael J. ; German, Matthew J. ; Singh, Maneesh et al. / IR microspectroscopy: potential applications in cervical cancer screening. In: Cancer Letters. 2007 ; Vol. 246, No. 1-2. pp. 1-11.

Bibtex

@article{10f52f536f6845cba69a801121236d61,
title = "IR microspectroscopy: potential applications in cervical cancer screening.",
abstract = "Screening exfoliative cytology for early dysplastic cells reduces incidence and mortality from squamous carcinoma of the cervix. In the developed world, screening programmes have adopted a 3–5 years recall system. In its absence, cervical cancer would be the second most common female cancer in these regions; instead, it is currently eleventh. However, there exist a number of limitations to the smear test even given the removal of contaminants using liquid-based cytology. It is prohibitively expensive, labour-intensive and subject to inaccuracies that give rise to significant numbers of false negatives. There remains a need for novel approaches to allow efficient and objective interrogation of exfoliative cytology. Methods that variously exploit infrared (IR) microspectroscopy are one possibility. Using IR microspectroscopy, an integrated {\textquoteleft}biochemical-cell fingerprint{\textquoteright} of the lipid, protein and carbohydrate composition of a biomolecular entity may be derived in the form of a spectrum via vibrational transitions of individual chemical bonds. Powerful statistical approaches (e.g. principal component analysis) now facilitate the interrogation of large amounts of spectroscopic data to allow the extraction of what may be small but extremely significant biomarker differences between disease-free and pre-malignant or malignant samples. An increasing wealth of literature points to the ability of IR microspectroscopy to allow the segregation of cells based on their disease status. We review the current evidence supporting its diagnostic potential in cancer biology.",
keywords = "Cervical cancer, Cytological screening, IR microspectroscopy, Principal component analysis, False negatives, Papanicolaou smear",
author = "Walsh, {Michael J.} and German, {Matthew J.} and Maneesh Singh and Pollock, {Hubert M.} and Azzedine Hammiche and Maria Kyrgiou and Stringfellow, {Helen F.} and Evangelos Paraskevaidis and Martin-Hirsch, {Pierre L.} and Martin, {Francis L.}",
year = "2007",
month = feb,
day = "8",
doi = "10.1016/j.canlet.2006.03.019",
language = "English",
volume = "246",
pages = "1--11",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

RIS

TY - JOUR

T1 - IR microspectroscopy: potential applications in cervical cancer screening.

AU - Walsh, Michael J.

AU - German, Matthew J.

AU - Singh, Maneesh

AU - Pollock, Hubert M.

AU - Hammiche, Azzedine

AU - Kyrgiou, Maria

AU - Stringfellow, Helen F.

AU - Paraskevaidis, Evangelos

AU - Martin-Hirsch, Pierre L.

AU - Martin, Francis L.

PY - 2007/2/8

Y1 - 2007/2/8

N2 - Screening exfoliative cytology for early dysplastic cells reduces incidence and mortality from squamous carcinoma of the cervix. In the developed world, screening programmes have adopted a 3–5 years recall system. In its absence, cervical cancer would be the second most common female cancer in these regions; instead, it is currently eleventh. However, there exist a number of limitations to the smear test even given the removal of contaminants using liquid-based cytology. It is prohibitively expensive, labour-intensive and subject to inaccuracies that give rise to significant numbers of false negatives. There remains a need for novel approaches to allow efficient and objective interrogation of exfoliative cytology. Methods that variously exploit infrared (IR) microspectroscopy are one possibility. Using IR microspectroscopy, an integrated ‘biochemical-cell fingerprint’ of the lipid, protein and carbohydrate composition of a biomolecular entity may be derived in the form of a spectrum via vibrational transitions of individual chemical bonds. Powerful statistical approaches (e.g. principal component analysis) now facilitate the interrogation of large amounts of spectroscopic data to allow the extraction of what may be small but extremely significant biomarker differences between disease-free and pre-malignant or malignant samples. An increasing wealth of literature points to the ability of IR microspectroscopy to allow the segregation of cells based on their disease status. We review the current evidence supporting its diagnostic potential in cancer biology.

AB - Screening exfoliative cytology for early dysplastic cells reduces incidence and mortality from squamous carcinoma of the cervix. In the developed world, screening programmes have adopted a 3–5 years recall system. In its absence, cervical cancer would be the second most common female cancer in these regions; instead, it is currently eleventh. However, there exist a number of limitations to the smear test even given the removal of contaminants using liquid-based cytology. It is prohibitively expensive, labour-intensive and subject to inaccuracies that give rise to significant numbers of false negatives. There remains a need for novel approaches to allow efficient and objective interrogation of exfoliative cytology. Methods that variously exploit infrared (IR) microspectroscopy are one possibility. Using IR microspectroscopy, an integrated ‘biochemical-cell fingerprint’ of the lipid, protein and carbohydrate composition of a biomolecular entity may be derived in the form of a spectrum via vibrational transitions of individual chemical bonds. Powerful statistical approaches (e.g. principal component analysis) now facilitate the interrogation of large amounts of spectroscopic data to allow the extraction of what may be small but extremely significant biomarker differences between disease-free and pre-malignant or malignant samples. An increasing wealth of literature points to the ability of IR microspectroscopy to allow the segregation of cells based on their disease status. We review the current evidence supporting its diagnostic potential in cancer biology.

KW - Cervical cancer

KW - Cytological screening

KW - IR microspectroscopy

KW - Principal component analysis

KW - False negatives

KW - Papanicolaou smear

U2 - 10.1016/j.canlet.2006.03.019

DO - 10.1016/j.canlet.2006.03.019

M3 - Journal article

VL - 246

SP - 1

EP - 11

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1-2

ER -